Ian Levine
Ian Levine is Co-founder and CEO at ModernVivo, where he leads the development of AI-enabled software to help life sciences companies optimize preclinical animal studies for drug discovery. He also serves as Founder in Residence at Foundations.
ModernVivo uses AI to analyze millions of animal studies, cutting literature review from weeks to minutes
ModernVivo, a Seattle startup, uses AI to scan millions of published animal studies and related data to help researchers design preclinical drug experiments faster, reducing literature review time from weeks to minutes and aiming to improve experiment quality while using fewer animals.
ModernVivo launches ModernVivo Marketplace on Sept. 15, 2026 to connect preclinical teams with pre-vetted CROs
ModernVivo announced on Sept. 15, 2026 the launch of ModernVivo Marketplace, a service to help preclinical R&D teams find pre-vetted CROs faster for in vivo study design and execution.
Seattle Early-Stage Startups Jinn Labs, ModernVivo, NailedIT Labs, and Onyx Platform Innovate with AI Across Multiple Industries
Four early-stage Seattle startups—Jinn Labs, ModernVivo, NailedIT Labs, and Onyx Platform—are leveraging AI and tech to address retail theft, preclinical studies, nail salon bookings, and insurance agency processes. Each company has distinct leadership and innovative approaches, ranging from computer vision to AI-driven appointment booking platforms.
Organizations
See all 5-
ModernVivo Co-Founder and CEO 2021–present · current
-
Foundations Founder in Residence 2025–present · current
-
miLEAD Consulting Consultant 2021–2022 · past
Education
-
University of Michigan Master of Science - MS, Pharmacology · 2021–2023
-
Virginia Tech Experimental Neuroscience · 2016–2020